Trade

with

Imprimis Pharmaceuticals Inc
(NASDAQ: IMMY)
AdChoices
8.86
+0.61
+7.39%
After Hours :
-
-
-

Open

8.25

Previous Close

8.25

Volume (Avg)

36.71k (24.45k)

Day's Range

8.23-9.24

52Wk Range

3.01-9.62

Market Cap.

80.90M

Dividend Rate ( Yield )

-

Beta

-1.28

Shares Outstanding

9.13M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 10.00k

    • Net Income

    • -7.64M

    • Market Cap.

    • 80.90M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,317.36

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -1.28

    • Forward P/E

    • -

    • Price/Sales

    • 119.05

    • Price/Book Value

    • 6.72

    • Price/Cash flow

    • -12.92

      • EBITDA

      • -7.64M

      • Return on Capital %

      • -55.06

      • Return on Equity %

      • -60.59

      • Return on Assets %

      • -55.06

      • Book Value/Share

      • 1.32

      • Shares Outstanding

      • 9.13M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -43.60

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 29.31

            • 82.75

            • Pre-Tax Margin

            • -1,317.36

            • 39.38

            • Net Profit Margin

            • -1,317.36

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.76

              • Current Ratio

              • 9.56

              • 2.92

              • Quick Ratio

              • 9.19

              • 2.35

              • Interest Coverage

              • -5,673.43

              • 38.02

              • Leverage Ratio

              • 1.15

              • 2.21

              • Book Value/Share

              • 1.32

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -8.12

                • 217.39

                • P/E Ratio 5-Year High

                • -75.13

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.51

                • 124.82

                • Price/Sales Ratio

                • 107.53

                • 9.52

                • Price/Book Value

                • 6.06

                • 8.61

                • Price/Cash Flow Ratio

                • -12.92

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -60.59

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -55.06

                        (-190.20)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -60.51

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 2.76

                      • 1.48

                      • Asset Turnover

                      • 0.04

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -7.69M
                      Operating Margin
                      -76,868.79
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -12.92
                      Ownership

                      Institutional Ownership

                      20.54%

                      Top 10 Institutions

                      20.40%

                      Mutual Fund Ownership

                      1.27%

                      Float

                      74.82%

                      5% / Insider Ownership

                      54.51%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        75,879

                      • 0.00

                      • 0.83

                      • iShares Micro-Cap

                      •  

                        18,246

                      • 0.00

                      • 0.22

                      • Vanguard Extended Market Index Fund

                      •  

                        11,791

                      • 0.00

                      • 0.13

                      • Fidelity® NASDAQ Composite Index® Fund

                      •  

                        2,451

                      • 0.00

                      • 0.03

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        1,162

                      • 0.00

                      • 0.01

                      • Fidelity® Nasdaq Composite Tr Stk Fund

                      •  

                        1,093

                      • 9.41

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Bard Associates Inc

                      •  

                        111,053

                      • 0.00%

                      • 1.22

                      • Vanguard Group, Inc.

                      •  

                        86,373

                      • +9.74%

                      • 0.95

                      • Revelation Capital Management Ltd

                      •  

                        80,500

                      • -14.81%

                      • 0.88

                      • Columbia Management Company

                      •  

                        75,949

                      • 0.00%

                      • 0.83

                      • Regions Financial Corp

                      •  

                        30,500

                      • 0.00%

                      • 0.33

                      • Marathon Capital Management LLC

                      •  

                        25,000

                      • 0.00%

                      • 0.27

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Imprimis Pharmaceuticals Inc is a development stage pharmaceutical company.

                      Key People

                      Mark L. Baum

                      CEO/Director

                      Dr. Robert J. Kammer

                      Chairman of the Board/Director

                      Mr. Andrew R. Boll

                      CFO/Chief Accounting Officer/Vice President, Divisional

                      Mr. William H. Nelson, Jr

                      Director

                      Mr. Steven G. Austin

                      Director

                      • Imprimis Pharmaceuticals Inc

                      • 12626 High Bluff Drive

                      • San Diego, CA 92130

                      • USA.Map

                      • Phone: +1 858 704-4040

                      • Fax: +1 858 345-1745

                      • imprimispharma.com

                      Incorporated

                      1998

                      Employees

                      17

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: